Advertisement

Index by Author

August 1999; 22 (8)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abbott, R D

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

  2. Abraham, M R

    • Hyperglycemic hyperosmolar nonketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser. Diabetes Care August 1999 22:1380-1381; doi:10.2337/diacare.22.8.1380

  3. Ahrén, B

    • Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330

  4. Aiello, L M

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  5. Aiello, L P

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  6. Alberto, M

    • Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers? Diabetes Care August 1999 22:1379-1380; doi:10.2337/diacare.22.8.1379

  7. Almgren, P

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

  8. Antonella, Q

    • Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers? Diabetes Care August 1999 22:1379-1380; doi:10.2337/diacare.22.8.1379

  9. Arora, V

    • Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group. Diabetes Care August 1999 22:1258-1261; doi:10.2337/diacare.22.8.1258

  10. Arslanian, S A

    • Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325

  11. Austin, E J

    • Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care August 1999 22:1273-1277; doi:10.2337/diacare.22.8.1273

  12. Azar, S T

    • Intensive insulin therapy compared with conventional insulin therapy does not reduce depressive symptoms in parents of children with type 1 diabetes. Diabetes Care August 1999 22:1372-1373; doi:10.2337/diacare.22.8.1372
    • Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a

B

  1. Baba, T

    • Hypoglycemia due to folk medicine. Diabetes Care August 1999 22:1376; doi:10.2337/diacare.22.8.1376b

  2. Balasekaran, G

    • Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325

  3. Balkau, B

    • Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care August 1999 22:1361-1363; doi:10.2337/diacare.22.8.1361
    • Fasting blood glucose and risk of cardiovascular disease. Diabetes Care August 1999 22:1385-1387; doi:10.2337/diacare.22.8.1385

  4. Barnett, A H

    • Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278

  5. Baron, A D

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

  6. Baz, P

    • Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a

  7. Bejjani, R

    • Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a

  8. Bhargava, N

    • Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318

  9. Bloomgarden, Z T

    • The European Association for the Study of Diabetes Annual Meeting, 1998: complications of diabetes. Diabetes Care August 1999 22:1364-1370; doi:10.2337/diacare.22.8.1364

  10. Bonadonna, R

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

  11. Bonora, E

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

  12. Bringer, J

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  13. Burak, W

    • Diagnosis of cardiac autonomic neuropathy in diabetic patients. Diabetes Care August 1999 22:1387-1388; doi:10.2337/diacare.22.8.1387

  14. Burchfiel, C M

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

  15. Bursell, S E

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  16. Burtner, C

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

C

  1. Capeau, J

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  2. Carpenter, S

    • Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care August 1999 22:1252-1257; doi:10.2337/diacare.22.8.1252

  3. Ceriello, A

    • Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? Diabetes Care August 1999 22:1384-1385; doi:10.2337/diacare.22.8.1384

  4. Clermont, A C

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  5. Costalat, G

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  6. Craft, S

    • Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318

  7. Cronin, J

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

  8. Cucuianu, M

    • Serum gamma-glutamyltransferase and/or serum cholinesterase as markers of the metabolic syndrome. Diabetes Care August 1999 22:1381-1382; doi:10.2337/diacare.22.8.1381

  9. Curb, J D

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

D

  1. Danadian, K

    • Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325

  2. Daniels, J E

    • Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278

  3. Daugaard, J R

    • Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330

  4. Deary, I J

    • Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care August 1999 22:1273-1277; doi:10.2337/diacare.22.8.1273

  5. Desbois-Mouthon, C

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  6. Dyer, P H

    • Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278

E

  1. Egger, G

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

  2. Eschwège, E

    • Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care August 1999 22:1361-1363; doi:10.2337/diacare.22.8.1361
    • Fasting blood glucose and risk of cardiovascular disease. Diabetes Care August 1999 22:1385-1387; doi:10.2337/diacare.22.8.1385

  3. Escudero, M

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  4. Ezio, F

    • Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers? Diabetes Care August 1999 22:1379-1380; doi:10.2337/diacare.22.8.1379

F

  1. Fabrizio, F

    • Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers? Diabetes Care August 1999 22:1379-1380; doi:10.2337/diacare.22.8.1379

  2. Feener, E P

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  3. Fontaine, P

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  4. Fujishima, M

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

G

  1. Garvey, W T

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

  2. Gibert-Boulet, F

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  3. Gomez, M

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  4. Groop, L

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

  5. Grzeszczak, W

    • Diagnosis of cardiac autonomic neuropathy in diabetic patients. Diabetes Care August 1999 22:1387-1388; doi:10.2337/diacare.22.8.1387

H

  1. Halabi, G

    • Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a

  2. Halvorson, M

    • Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care August 1999 22:1252-1257; doi:10.2337/diacare.22.8.1252

  3. Hanefeld, M

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

  4. Harris, N D

    • Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292

  5. Harris, T

    • Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278

  6. Hasche, H

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

  7. Henricsson, M

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

  8. Hernandez-Mijares, A

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  9. Hershey, T

    • Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318

  10. Hirahashi, T

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

  11. Hook, G

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

I

  1. Isomaa, B

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

  2. Itakura, M

    • Hypoglycemia due to folk medicine. Diabetes Care August 1999 22:1376; doi:10.2337/diacare.22.8.1376b

  3. Iwase, M

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

J

  1. Jacques-Apostol, D

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  2. Jaffiol, C

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  3. Jain, S K

    • Should high-dose vitamin E supplementation be recommended to diabetic patients? Diabetes Care August 1999 22:1242-1244; doi:10.2337/diacare.22.8.1242

  4. Jarrett, R J

    • Fasting blood glucose and risk of cardiovascular disease. Diabetes Care August 1999 22:1385-1387; doi:10.2337/diacare.22.8.1385

  5. Johnson, A

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

K

  1. Kanaan, N

    • Intensive insulin therapy compared with conventional insulin therapy does not reduce depressive symptoms in parents of children with type 1 diabetes. Diabetes Care August 1999 22:1372-1373; doi:10.2337/diacare.22.8.1372

  2. Kataoka, K

    • Hypoglycemia due to folk medicine. Diabetes Care August 1999 22:1376; doi:10.2337/diacare.22.8.1376b

  3. Kaufman, F R

    • Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care August 1999 22:1252-1257; doi:10.2337/diacare.22.8.1252

  4. Kerum, G

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

  5. Khardori, R

    • Hyperglycemic hyperosmolar nonketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser. Diabetes Care August 1999 22:1380-1381; doi:10.2337/diacare.22.8.1380

  6. Kiechl, S

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

  7. Kiens, B

    • Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330

  8. King, G L

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  9. Kraemer, F B

    • Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302

L

  1. Laffel, L

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  2. Lancashire, R J

    • Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278

  3. Larsson, H

    • Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330

  4. Lau, N

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

  5. Lauton, D

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  6. Leaming, R

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

  7. Lefebvre, J

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  8. Lewy, V

    • Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325

  9. Lindström, T

    • Sustained improvement of glycemic control by insulin treatment after 9 years in patients with type 2 diabetes and secondary failure. Diabetes Care August 1999 22:1373-1374; doi:10.2337/diacare.22.8.1373

  10. Lloyd, C E

    • Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278

  11. Lluch,

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  12. Lobisch, M

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

M

  1. Magré, J

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  2. Mah, C A

    • Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302

  3. Malessa, R

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

  4. Martinez-Triguero, M L

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  5. McGarvey, S T

    • Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care August 1999 22:1284-1291; doi:10.2337/diacare.22.8.1284

  6. McPhee, S J

    • Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302

  7. Medlej, R

    • Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a

  8. Merino, M A

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  9. Meza, M P

    • Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325

  10. Morillas, C

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

  11. Motz, E

    • Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? Diabetes Care August 1999 22:1384-1385; doi:10.2337/diacare.22.8.1384

  12. Muggeo, M

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

  13. Muñoz, M L

    • Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378

O

  1. Oberhollenzer, F

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

  2. Okamura, C

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

P

  1. Paradisi, G

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

  2. Patrizia, C

    • Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers? Diabetes Care August 1999 22:1379-1380; doi:10.2337/diacare.22.8.1379

  3. Pattou, F

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  4. Piette, J D

    • Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302

  5. Pyörälä, K

    • Fasting blood glucose and risk of cardiovascular disease. Diabetes Care August 1999 22:1385-1387; doi:10.2337/diacare.22.8.1385

R

  1. Rajbhandari, S M

    • Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292

  2. Renard, E

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  3. Richter, E A

    • Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330

  4. Roach, P

    • Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group. Diabetes Care August 1999 22:1258-1261; doi:10.2337/diacare.22.8.1258

  5. Robertson, R

    • Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325

  6. Rodriguez, B L

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

  7. Ruhnau, K J

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

  8. Ryan, C M

    • Memory and metabolic control in children. Diabetes Care August 1999 22:1239-1241; doi:10.2337/diacare.22.8.1239

S

  1. Sadler, M

    • Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318

  2. Saint-Paul, M

    • Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care August 1999 22:1361-1363; doi:10.2337/diacare.22.8.1361

  3. Salti, I

    • Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a

  4. Sarelin, L

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

  5. Schlossman, D K

    • High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245

  6. Schütte, K

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

  7. Senan, C

    • Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care August 1999 22:1361-1363; doi:10.2337/diacare.22.8.1361

  8. Shaper, A G

    • Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care August 1999 22:1266-1272; doi:10.2337/diacare.22.8.1266

  9. Sharp, D S

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

  10. Simon, D

    • Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care August 1999 22:1361-1363; doi:10.2337/diacare.22.8.1361

  11. Smith, L

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

  12. Souche, C

    • Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371

  13. Steinberg, H O

    • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310

T

  1. Taskinen, M R

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

  2. Tesfaye, S

    • Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292

  3. Thibult, N

    • Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care August 1999 22:1361-1363; doi:10.2337/diacare.22.8.1361

  4. Tsuji, H

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

  5. Tucker, R

    • Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care August 1999 22:1284-1291; doi:10.2337/diacare.22.8.1284

  6. Tuomi, T

    • Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347

V

  1. Vantyghem, M C

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  2. Vigouroux, C

    • Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374

  3. Vohr, B R

    • Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care August 1999 22:1284-1291; doi:10.2337/diacare.22.8.1284

W

  1. Wannamethee, S G

    • Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care August 1999 22:1266-1272; doi:10.2337/diacare.22.8.1266

  2. Ward, J D

    • Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292

  3. Weinberger, M

    • Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302

  4. White, N H

    • Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318

  5. Willeit, J

    • Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339

Y

  1. Yamaguchi, M

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

  2. Yano, K

    • Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262

  3. Yoshinari, M

    • A Japanese case of liver dysfunction after 19 months of troglitazone treatment. Diabetes Care August 1999 22:1382-1384; doi:10.2337/diacare.22.8.1382

  4. Yue, L

    • Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group. Diabetes Care August 1999 22:1258-1261; doi:10.2337/diacare.22.8.1258

Z

  1. Ziegler, D

    • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement